Responses
Diabetes and endocrinology
Protocol
Protocol of the adaptive study of IL-2 dose frequency on regulatory T cells in type 1 diabetes (DILfrequency): a mechanistic, non-randomised, repeat dose, open-label, response-adaptive study
Compose a Response to This Article
Other responses
No responses have been published for this article.